... @peppers1
I don't think everything needs to go right here. If everything goes right we are way over $3.50.
Kaken was selling to 16% of their market in year 1.
If everything goes right, and BOT sells to 15% of it's market in year 1.
570,000 patients ( 4 scripts each )
2.28 Million scripts at 750 USD each
1.7B USD gross sales
Approx $500M USD profit ( 750M AUD )
PE 15 $ 11B AUD MC.... about $8 per share.
If everything was going right though, the PE would be higher than 15, more like 30
$16 per share.
We need to gauge success on something, why not what Kaken achieved in year 1?
Bot Chart, page-13557
-
- There are more pages in this discussion • 1,313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.784M | 4.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248028 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 356327 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |